Emeryville, CA, United States of America

Adamas Pharma, LLC


USPTO Granted Patents = 11

Trademarks = 4

Forward Citations = 111

Loading Chart...
Loading Chart...

10 inventors (with patents filed for the assignee):

goldMedal Gregory T Went (11 out of 40 patents)

silverMedal Natalie McClure (6 out of 6 patents)

bronzeMedal Timothy J Fultz (6 out of 44 patents)

4.  Gangadhara Ganapati (5 out of 10 patents)

5.  Gayatri Sathyan (5 out of 6 patents)

6.  Kavita Vermani (5 out of 6 patents)

7.  Michael Coffee (5 out of 10 patents)

8.  Efraim Shek (5 out of 6 patents)

9.  Ashok Katdare (5 out of 6 patents)

10.  Sangita Ghosh (3 out of 5 patents)


11 patents:

Company Overview
Adamas Pharma, LLC, based in Emeryville, California, specializes in the development of innovative therapies for neurological disorders. The company focuses on addressing unmet medical needs through its proprietary drug delivery technologies and formulations. With a commitment to improving patient outcomes, Adamas Pharma leverages its expertise in pharmacology and neuroscience to create effective treatments for conditions such as Parkinson's disease and other chronic neurological conditions. Their research emphasizes precision medicine and tailored therapeutic solutions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

11 Patents

#51 in Emeryville, CA

#6,544 in California

#27,529 in US

#51,801 in the World

Emeryville, CA (US)
Emeryville, CA, United States of America
Forward Citations = 111

10 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Adamas Pharma, LLC. Retrieved from https://idiyas.com/company/adamas-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…